-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, HQTKgFqSX36N014tjTBpRA+iLRR3yd7P6A5temjq7yWabvDn+nFDW3YpOD4B3K5s psJJnjxGm6fi4ERT8lt1sQ== 0000812796-97-000006.txt : 19970306 0000812796-97-000006.hdr.sgml : 19970306 ACCESSION NUMBER: 0000812796-97-000006 CONFORMED SUBMISSION TYPE: 8-K/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 19970131 ITEM INFORMATION: Change in fiscal year FILED AS OF DATE: 19970305 SROS: NASD FILER: COMPANY DATA: COMPANY CONFORMED NAME: ENDOREX CORP CENTRAL INDEX KEY: 0000812796 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 411505029 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K/A SEC ACT: 1934 Act SEC FILE NUMBER: 000-16929 FILM NUMBER: 97550796 BUSINESS ADDRESS: STREET 1: 3233 15TH STREET SOUTH CITY: FARGO STATE: ND ZIP: 58104 BUSINESS PHONE: 7012329575 MAIL ADDRESS: STREET 1: 3233 15TH STREET SOUTH CITY: FARGO STATE: ND ZIP: 58104 FORMER COMPANY: FORMER CONFORMED NAME: IMMUNOTHERAPEUTICS INC DATE OF NAME CHANGE: 19920703 8-K/A 1 CHANGE IN FISCAL YEAR SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT #1 TO FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) January 31, 1997 ----------------------------------------------------------------- Endorex Corp. ------------------------------------------------------ (Exact name of registrant as specified in its charter) DELAWARE ---------------------------------------------- (State or other jurisdiction of incorporation) 0-16929 41-1505029 -------------------------------------------------------------- (Commission File Number) (IRS Employer Identification No.) 900 North Shore Drive, Lake Bluff, IL 60044 ---------------------------------------------------------- (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code: (847) 604-7555 -------------- --------------------------------------------------------------------- (Former name or former address, if changed since last report) ITEM 8. CHANGE IN FISCAL YEAR. --------------------- On January 31, 1997, the Board of Directors of Endorex Corp. (the Company) resolved to change the Company's fiscal year end from January 31 to December 31. The transition period resulting from the change in fiscal year will be reported on the Company's Annual Report on Form 10-KSB for the year ended December 31,1996. Pursuant to the requirements of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Endorex Corp. March 5, 1997 /s/ Michael S. Rosen --------------------------------------- President and Chief Executive Officer -----END PRIVACY-ENHANCED MESSAGE-----